Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 286

1.

Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization.

Pannone G, Rodolico V, Santoro A, Lo Muzio L, Franco R, Botti G, Aquino G, Pedicillo MC, Cagiano S, Campisi G, Rubini C, Papagerakis S, De Rosa G, Tornesello ML, Buonaguro FM, Staibano S, Bufo P.

Infect Agent Cancer. 2012 Feb 29;7:4. doi: 10.1186/1750-9378-7-4.

2.

Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.

Prigge ES, Arbyn M, von Knebel Doeberitz M, Reuschenbach M.

Int J Cancer. 2017 Mar 1;140(5):1186-1198. doi: 10.1002/ijc.30516. Epub 2016 Dec 2. Review.

PMID:
27859245
3.

Identification of transcriptionally active HPV infection in formalin-fixed, paraffin-embedded biopsies of oropharyngeal carcinoma.

Morbini P, Alberizzi P, Tinelli C, Paglino C, Bertino G, Comoli P, Pedrazzoli P, Benazzo M.

Hum Pathol. 2015 May;46(5):681-9. doi: 10.1016/j.humpath.2014.12.014. Epub 2015 Jan 14.

PMID:
25708613
4.

The role of human papillomavirus in p16-positive oral cancers.

Belobrov S, Cornall AM, Young RJ, Koo K, Angel C, Wiesenfeld D, Rischin D, Garland SM, McCullough M.

J Oral Pathol Med. 2018 Jan;47(1):18-24. doi: 10.1111/jop.12649. Epub 2017 Oct 30.

PMID:
29024035
5.

Ultrasensitive detection of oncogenic human papillomavirus in oropharyngeal tissue swabs.

Isaac A, Kostiuk M, Zhang H, Lindsay C, Makki F, O'Connell DA, Harris JR, Cote DW, Seikaly H, Biron VL.

J Otolaryngol Head Neck Surg. 2017 Jan 14;46(1):5. doi: 10.1186/s40463-016-0177-8.

6.

Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.

Jordan RC, Lingen MW, Perez-Ordonez B, He X, Pickard R, Koluder M, Jiang B, Wakely P, Xiao W, Gillison ML.

Am J Surg Pathol. 2012 Jul;36(7):945-54. doi: 10.1097/PAS.0b013e318253a2d1.

PMID:
22743284
7.

High-risk HPV genotypes and P16INK4a expression in a cohort of head and neck squamous cell carcinoma patients in Singapore.

Tan LS, Fredrik P, Ker L, Yu FG, Wang Y, Goh BC, Loh KS, Lim CM.

Oncotarget. 2016 Dec 27;7(52):86730-86739. doi: 10.18632/oncotarget.13502.

8.

Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.

Bishop JA, Ma XJ, Wang H, Luo Y, Illei PB, Begum S, Taube JM, Koch WM, Westra WH.

Am J Surg Pathol. 2012 Dec;36(12):1874-82. doi: 10.1097/PAS.0b013e318265fb2b.

9.

Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany.

Hauck F, Oliveira-Silva M, Dreyer JH, Perrusi VJ, Arcuri RA, Hassan R, Bonvicino CR, Barros MH, Niedobitek G.

Virchows Arch. 2015 Jun;466(6):685-93. doi: 10.1007/s00428-015-1761-4. Epub 2015 Mar 28.

PMID:
25820374
10.

β-Catenin Expression in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16 and Human Papillomavirus in situ Hybridization.

Nwanze J, Cohen C, Schmitt AC, Siddiqui MT.

Acta Cytol. 2015;59(6):479-84. doi: 10.1159/000443602. Epub 2016 Feb 6.

PMID:
26849661
11.

Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination.

Schache AG, Liloglou T, Risk JM, Filia A, Jones TM, Sheard J, Woolgar JA, Helliwell TR, Triantafyllou A, Robinson M, Sloan P, Harvey-Woodworth C, Sisson D, Shaw RJ.

Clin Cancer Res. 2011 Oct 1;17(19):6262-71. doi: 10.1158/1078-0432.CCR-11-0388.

12.

Differences in the Prevalence of Human Papillomavirus (HPV) in Head and Neck Squamous Cell Cancers by Sex, Race, Anatomic Tumor Site, and HPV Detection Method.

D'Souza G, Westra WH, Wang SJ, van Zante A, Wentz A, Kluz N, Rettig E, Ryan WR, Ha PK, Kang H, Bishop J, Quon H, Kiess AP, Richmon JD, Eisele DW, Fakhry C.

JAMA Oncol. 2016 Dec 8. doi: 10.1001/jamaoncol.2016.3067. [Epub ahead of print]

PMID:
27930766
14.

Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.

Biron VL, Kostiuk M, Isaac A, Puttagunta L, O'Connell DA, Harris J, Côté DW, Seikaly H.

Cancer. 2016 May 15;122(10):1544-51. doi: 10.1002/cncr.29976. Epub 2016 Mar 17.

15.

A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer.

Schlecht NF, Brandwein-Gensler M, Nuovo GJ, Li M, Dunne A, Kawachi N, Smith RV, Burk RD, Prystowsky MB.

Mod Pathol. 2011 Oct;24(10):1295-305. doi: 10.1038/modpathol.2011.91. Epub 2011 May 13.

16.

p16 - a Possible Surrogate Marker for High-Risk Human Papillomaviruses in Oral Cancer?

Sritippho T, Pongsiriwet S, Lertprasertsuke N, Buddhachat K, Sastraruji T, Iamaroon A.

Asian Pac J Cancer Prev. 2016;17(8):4049-57.

17.

Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators--a pilot study.

Bussu F, Sali M, Gallus R, Petrone G, Zannoni GF, Autorino R, Dinapoli N, Santangelo R, Vellone VG, Graziani C, Miccichè F, Almadori G, Galli J, Delogu G, Sanguinetti M, Rindi G, Tommasino M, Valentini V, Paludetti G.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1115-20. doi: 10.1016/j.ijrobp.2014.04.044. Epub 2014 Jul 8.

PMID:
25035216
18.

HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker?

Bussu F, Sali M, Gallus R, Vellone VG, Zannoni GF, Autorino R, Dinapoli N, Santangelo R, Martucci R, Graziani C, Miccichè F, Almadori G, Galli J, Delogu G, Sanguinetti M, Rindi G, Valentini V, Paludetti G.

Br J Cancer. 2013 Mar 19;108(5):1157-62. doi: 10.1038/bjc.2013.55. Epub 2013 Feb 12.

19.

High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.

Ukpo OC, Flanagan JJ, Ma XJ, Luo Y, Thorstad WL, Lewis JS Jr.

Am J Surg Pathol. 2011 Sep;35(9):1343-50. doi: 10.1097/PAS.0b013e318220e59d.

PMID:
21836494
20.

Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma.

Shi W, Kato H, Perez-Ordonez B, Pintilie M, Huang S, Hui A, O'Sullivan B, Waldron J, Cummings B, Kim J, Ringash J, Dawson LA, Gullane P, Siu L, Gillison M, Liu FF.

J Clin Oncol. 2009 Dec 20;27(36):6213-21. doi: 10.1200/JCO.2009.23.1670. Epub 2009 Nov 2.

PMID:
19884544

Supplemental Content

Support Center